Psychedelic therapies are evolving showing unprecented results. These results are being noted in non-traditional medical, therapeutic, and community environments creating unknowns of traditional systems leaving them paralyzed as to how to move forward.
The psychedelic medicine class includes a variety of substances with various opinions as to how they should be classified. Research has shown that the psychedelic class of medications will include several subclasses of medications including ketamine, psilocybin, ibogaine, ayahuasca, LSD and others with many of them currently being illegal in the United States making access to these substances impossible unless sourcing illegally through the underground market.
Recognizing ketamine has been approved in the United States since 1970 and is legally accessible in every medical providers prescribing license under the DEA, we have created the solution to move psychedelic therapies forward by treating 100,000 Veterans, following the results, and presenting the appropirate materials to all necessary professional and governmental bodies in the United States in order to blaze the necessary path forward for all psychedelic medications creating an equitable environment for all to be treated with emphasis on affordability, quality, and gold standard care.
Kommentare